NCOA4 and ovarian carcinoma: The immunohistochemical staining results confirmed that compared with low-grade ovarian cancer samples, C-MYC showed obvious over-expression and NCOA4 revealed significant inhibition in high-grade ovarian cancer tissues (Figure 1A,B).